HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Forecast Calls For Higher Volume, Lower Profit On Spending

This article was originally published in The Rose Sheet

Executive Summary

Colgate's effort to boost marketing support to maintain leading share positions is fueling volume sales and market share growth, but also will result in lower than expected earnings in the second half of the year, Chairman and CEO Reuben Mark warned investors during a conference call Sept. 20

You may also be interested in...



Colgate Brushes Up Its Bottom Line With Restructuring Initiative

Colgate is undertaking a four-year restructuring and business-building plan aimed at increasing the company's gross profit and operating profit by generating annual savings of $250 mil.-$300 mil. after tax by the fourth year. After tax savings in 2005 are expected to be approximately $45 mil

Colgate Brushes Up Its Bottom Line With Restructuring Initiative

Colgate is undertaking a four-year restructuring and business-building plan aimed at increasing the company's gross profit and operating profit by generating annual savings of $250 mil.-$300 mil. after tax by the fourth year. After tax savings in 2005 are expected to be approximately $45 mil

Colgate

"Quiet innovations," or product launches that are not highly publicized, are key to building Colgate's long-term business, CEO Reuben Mark says during recent presentation at the Morgan Stanley Global Consumer Conference in New York City. Exec cites Colgate launches such as Simply White and Max Fresh toothpastes, as well as the upcoming 360° toothbrush with tongue cleaner as examples of "quiet innovations" which will continue to generate sales. Mark also reassured analysts that Colgate's global business remains strong despite the firm's recent decision to lower its earnings targets for the third and fourth quarters (1"The Rose Sheet" Sept. 27, 2004, p. 8). Colgate will continue to focus on core categories and growing market share and expects earnings per share to be $.06-$.10 next year, he adds...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel